Research storefront The trusted peptide source for verified quality, dependable research support, and independent analysis
As a triple incretin receptor agonist, it: Activates GLP-1 receptors , reducing appetite, slowing gastric emptying, and improving insulin secretion Activates GIP receptors , enhancing insulin response and potentially supporting fat metabolism Activates glucagon receptors , increasing energy expenditure and hepatic glucose output Whilst glucagon receptor activation increases hepatic glucose output, the net glycaemic effect of retatrutide is mitigated by the concurrent GLP-1 and GIP activity, resulting in overall improvements in glycaemic control in trial participants
These murine models were then presented with BPC-157 to illustrate its action
Lancet (London, England) 375(9733):22152222
Timing matters: MOTS-c is most effective during fasted states or pre-training windows, while 5-amino-1MQ maintains NAD+ elevation when dosed consistently daily